According to the Endocrine Society clinical guidelines, screening for<unk><unk>  is recommended every 3 years among patients with one or more risk factors (type 2 diabetes or with a family history of dyslipidemia, cardiovascular diseases, or hereditary conditions associated with cardiovascular mortality such as polycystic ovary<unk> , and in cases of childhood obesity).
Metabolic syndrome screening
Obesity screening
Smoking screening
Low density lipoprotein screening
High density lipoprotein screening
Peripheral arterial disease screening
Cyanosis screening
Goiter screening